PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463132
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463132
The global serum separation gel market size is expected to reach USD 11.96 billion by 2032, according to a new study by Polaris Market Research. The report "Serum Separation Gel Market Share, Size, Trends, Industry Analysis Report, By Product Type (Serum Separation Gel integrated with Tube and Serum Separation Gel without Tube); By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The upsurge in the number of blood banks globally, the growing use of serum separation gels in various healthcare settings, including hospitals, clinics, and research & academics, and the growing occurrence of bloodstream infections are prominent factors driving the global market growth. Growing need for accurate and advanced diagnostic testing facilities as a result of the increased prevalence of diseases worldwide, driving the adoption of serum separation gels as they are essential components of several diagnostic assays.
For instance, according to a report by the National Institute of Health, bloodstream infections are one of the major causes of illness and death worldwide. The incidence of these infections has increased to 122 to 220 cases per 100,000 population. These infections cause around 250,000 deaths every year in Europe and North America.
Furthermore, the adoption and demand for serum separation gels are also attributed to their ability to allow for stable and reliable separation of blood cots and serum with very little impact on clinical test findings, which makes them a highly suitable option for diagnostic testing. Over the years, serum separation gels have expanded their range of uses from clinical diagnostics to research applications, including genomics and proteomics, which is further contributing to the market growth.
With the emerging trend towards personalized medicine, there is a lucrative opportunity for product manufacturers to develop customized separation gel products catering to specific patient or diagnostic requirements. Also, the drastic shift towards point-of-care testing that allows for convenient and rapid diagnostic testing presents an opportunity for manufacturers to develop products that are specially tailored to these settings. As the incidences of diseases increase, the need for innovative diagnostic testing facilities and tests will also grow rapidly and propel the demand for serum separation gels.
For instance, according to the Centers for Disease Control and Prevention, more than 14 billion laboratory clinical tests are ordered annually in the US, and there are over 260,000 CLIA-certified laboratories in the US.
Serum separation gel integrated with tube segment accounted for the largest share, owing to its significant use in clinical research to manage infectious disease burden
Blood banks segment led the market, which is attributed to an increased number of blood banks and rising awareness among people about the awareness of blood donation
North America dominated the global market on account of the rising prevalence of hematological disorders and the presence of well-established healthcare infrastructure
The key market players include Narang Medical Limited, Sekisui Chemical, Thermo Fisher Scientific, Qiagen NV, Corning Incorporated, and BD Biosciences
Polaris Market Research has segmented the serum separation gel market report based on product type, end user, and region: